X. Artignan
AuthID: R-00K-0R8
1
TÃTULO: A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse: The PEACE 2 trial from Unicancer
AUTORES: Blanchard, P; Foulon, S; Artignan, X; Carles, J; Ronchin, P; Gizzi, M; Freixa, SV; Valdagni, R; Sargos, P; Da Costa, LAM; Duberge, T; Guillot, A; Latorzeff, I; Gallardo, E; Saez, MI; Abadie Lacourtoisie, S; Bennamoun, M; Hasbini, A; Tantot, F; Fizazi, K;
PUBLICAÇÃO: 2021, FONTE: ANNALS OF ONCOLOGY, VOLUME: 32
AUTORES: Blanchard, P; Foulon, S; Artignan, X; Carles, J; Ronchin, P; Gizzi, M; Freixa, SV; Valdagni, R; Sargos, P; Da Costa, LAM; Duberge, T; Guillot, A; Latorzeff, I; Gallardo, E; Saez, MI; Abadie Lacourtoisie, S; Bennamoun, M; Hasbini, A; Tantot, F; Fizazi, K;
PUBLICAÇÃO: 2021, FONTE: ANNALS OF ONCOLOGY, VOLUME: 32
INDEXADO EM: 
WOS
WOS